LLY

757.36

+3.2%↑

JNJ

151.29

+1.18%↑

UNH

291.24

+6.59%↑

ABBV

183.96

+1.27%↑

NVO

64.34

-2.56%↓

LLY

757.36

+3.2%↑

JNJ

151.29

+1.18%↑

UNH

291.24

+6.59%↑

ABBV

183.96

+1.27%↑

NVO

64.34

-2.56%↓

LLY

757.36

+3.2%↑

JNJ

151.29

+1.18%↑

UNH

291.24

+6.59%↑

ABBV

183.96

+1.27%↑

NVO

64.34

-2.56%↓

LLY

757.36

+3.2%↑

JNJ

151.29

+1.18%↑

UNH

291.24

+6.59%↑

ABBV

183.96

+1.27%↑

NVO

64.34

-2.56%↓

LLY

757.36

+3.2%↑

JNJ

151.29

+1.18%↑

UNH

291.24

+6.59%↑

ABBV

183.96

+1.27%↑

NVO

64.34

-2.56%↓

Search

10X Genomics Inc (Class A)

Geschlossen

BrancheGesundheitswesen

9.4 2.62

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

8.93

Max

9.4

Schlüsselkennzahlen

By Trading Economics

Einkommen

15M

-34M

Verkäufe

-10M

155M

EPS

-0.102

Gewinnspanne

-22.183

Angestellte

1,306

EBITDA

-1.5M

-39M

Empfehlungen

By TipRanks

Empfehlungen

Buy

12-Monats-Prognose

+37.72% upside

Dividenden

By Dow Jones

Nächstes Ergebnis

7. Aug. 2025

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

108M

1.2B

Vorheriger Eröffnungskurs

6.78

Vorheriger Schlusskurs

9.4

Nachrichtenstimmung

By Acuity

50%

50%

177 / 382 Ranking in Healthcare

Technischer Score

By Trading Central

Vertrauen

Bullish Evidence

10X Genomics Inc (Class A) Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

16. Mai 2025, 19:39 UTC

Wichtige Markttreiber

UroGen Falls to 52-Week Low, FDA Document Indicates Cancer Drug Study Disagreement

16. Mai 2025, 23:18 UTC

Top News

U.S. Loses Last Triple-A Credit Rating -- 2nd Update

16. Mai 2025, 22:30 UTC

Top News

U.S. Loses Last Triple-A Credit Rating -- Update

16. Mai 2025, 21:56 UTC

Market Talk

Fitch Raises Greece's Outlook to Positive From Stable -- Market Talk

16. Mai 2025, 21:56 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

16. Mai 2025, 21:54 UTC

Top News

U.S. Loses Last Triple-A Credit Rating -- WSJ

16. Mai 2025, 21:22 UTC

Market Talk

Moody's Says U.S. Fiscal Performance Likely to Deteriorate -- Market Talk

16. Mai 2025, 21:17 UTC

Market Talk

Treasury Yields Rise, Dollar Falls After Moody's Cuts U.S. Credit Rating -- Market Talk

16. Mai 2025, 21:17 UTC

Top News

The Score: UnitedHealth, Walmart, Coinbase Global and More Stocks That Moved on the Week's News -- WSJ

16. Mai 2025, 21:05 UTC

Market Talk

Moody's Downgrades U.S. Credit Rating Due to Deficit, Debts -- Market Talk

16. Mai 2025, 20:55 UTC

Akquisitionen, Fusionen, Übernahmen

What's Next for Cable Giant Comcast After Charter-Cox Merger -- Barrons.com

16. Mai 2025, 20:50 UTC

Market Talk
Ergebnisse

Financial Services Roundup: Market Talk

16. Mai 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

16. Mai 2025, 20:37 UTC

Top News

Trade Progress Sparks Bullish Week for Wall Street -- WSJ

16. Mai 2025, 20:33 UTC

Market Talk
Akquisitionen, Fusionen, Übernahmen

Dick's-Foot Locker Deal Looks Like a Bet on Nike's Turnaround -- Market Talk

16. Mai 2025, 20:30 UTC

Akquisitionen, Fusionen, Übernahmen

Galaxy Digital Begins U.S. Trading as Bitcoin Keeps Powering Ahead -- Barrons.com

16. Mai 2025, 20:18 UTC

Top News

Major U.S. Stock Indexes Rise; U.S. Running Out of Patience for Trade Deals -- WSJ

16. Mai 2025, 20:16 UTC

Top News

Justice Department Wants to Spare Boeing From Guilty Plea Over 737 MAX Charges -- 3rd Update

16. Mai 2025, 20:15 UTC

Ergebnisse

Tesla Stock Rises. Even Hedge Fund Sales Can't Keep It Down. -- Barrons.com

16. Mai 2025, 20:11 UTC

Akquisitionen, Fusionen, Übernahmen

Henry Schein: William K. Daniel Joins Board

16. Mai 2025, 20:10 UTC

Akquisitionen, Fusionen, Übernahmen

Henry Schein: Strategic Investment by KKR Completed

16. Mai 2025, 20:05 UTC

Akquisitionen, Fusionen, Übernahmen

What's Next for Cable Giant Comcast After Charter-Cox Merger -- Barrons.com

16. Mai 2025, 19:38 UTC

Market Talk

Oil Futures Post Second Straight Weekly Gain -- Market Talk

16. Mai 2025, 19:07 UTC

Market Talk

U.S. Natural Gas Futures End Week Lower -- Market Talk

16. Mai 2025, 18:51 UTC

Top News

Early Read on Consumer Sentiment Falls to Second Lowest on Record -- 5th Update

16. Mai 2025, 18:41 UTC

Akquisitionen, Fusionen, Übernahmen

What's Next for Cable Giant Comcast After Charter-Cox Merger -- Barrons.com

16. Mai 2025, 18:37 UTC

Market Talk

Gold Futures End Week on Negative Note -- Market Talk

16. Mai 2025, 18:35 UTC

Top News

Ozempic Drugmaker's CEO Pushed Out Amid Weight-Loss Market Challenges -- 3rd Update

16. Mai 2025, 18:32 UTC

Top News

Trump Floats Plan to Impose New Tariff Rates; Stocks Hold Steady -- WSJ

16. Mai 2025, 18:28 UTC

Market Talk

Weaker Dollar Seen as Helping Some Business to Avoid Price Increases -- Market Talk

Peer-Vergleich

Kursveränderung

10X Genomics Inc (Class A) Prognose

Kursziel

By TipRanks

37.72% Vorteil

12-Monats-Prognose

Durchschnitt 12.56 USD  37.72%

Hoch 15 USD

Tief 9 USD

Basierend auf 11 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für 10X Genomics Inc (Class A) – Dist angeboten haben.

Rating-Konsens

By TipRanks

Buy

11 ratings

4

Buy

7

Halten

0

Sell

Technischer Score

By Trading Central

8.32 / 8.63Unterstützung & Widerstand

Kurzfristig

Bullish Evidence

Mittelfristig

Bullish Evidence

Langfristig

No Evidence

Stimmung

By Acuity

177 / 382 Ranking in Gesundheitswesen

Nachrichtenstimmung

Neutral

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Unterdurchschnittlich

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über 10X Genomics Inc (Class A)

10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in the America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium, chromium connect, and chromium controller instruments, microfluidic chips, slides, reagents, and other consumables products. Its single cell solutions runs on its chromium instruments, which include single cell gene expression for measuring gene activity and networks on a cell-by-cell basis; single cell gene expression flex; single cell immune profiling used to study the immune system; single cell Assay for Transposase Accessible Chromati (ATAC) solution to understand the epigenetic state; and single cell multiome ATAC + gene expression which enables simultaneous interrogation of both the RNA and chromatin accessibility, using ATAC in a single cell. The company also provides Visium platform which enables researchers to understand the spatial positions of biological analytes within tissues at high resolution; and Xenium platform for in situ analysis. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.